Details for Patent: 4,301,146
✉ Email this page to a colleague
Summary for Patent: 4,301,146
Title: | Stabilization of 16-oxygenated prostanoic acid derivatives |
Abstract: | A stable solid dosage form of the compound .+-.methyl(7-[3(.alpha.)-hydroxy-2-.beta.-(4(RS)-4-hydroxy-4-methyl-trans- 1-octen-1-yl)-oxycyclopent-1.alpha.-yl]heptanoate, said solid dosage form comprising from about 50 to about 500 parts of a polymer selected from the group consisting of hydroxypropylmethyl cellulose and polyvinylpyrolidone per part of said compound. |
Inventor(s): | Sanvordeker; Dilip R. (Elk Grove Village, IL) |
Assignee: | G. D. Searle & Co. (Skokie, IL) |
Application Number: | 06/173,292 |
Patent Claim Types: see list of patent claims | Compound; Dosage form; |
Drugs Protected by US Patent 4,301,146
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |